- Drug Pipelines
- August 2023
- 400 Pages
China
From €2863EUR$3,000USD£2,399GBP
- Report
- June 2022
- 1500 Pages
Global
From €3722EUR$3,900USD£3,119GBP
- Drug Pipelines
- March 2022
- 900 Pages
Global
From €8589EUR$9,000USD£7,197GBP
- Report
- December 2021
- 120 Pages
Global
From €3149EUR$3,300USD£2,639GBP
- Report
- September 2022
- 247 Pages
Global
From €2505EUR$2,625USD£2,099GBP
€5010EUR$5,250USD£4,198GBP
- Report
- September 2024
- 120 Pages
China
From €5679EUR$5,950USD£4,758GBP
- Report
- January 2023
- 189 Pages
Global
From €4008EUR$4,200USD£3,358GBP
- Report
- February 2024
- 250 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- January 2024
- 261 Pages
Global
From €2338EUR$2,450USD£1,959GBP
- Report
- April 2021
China
From €2481EUR$2,600USD£2,079GBP
- Report
- March 2024
- 100 Pages
North America
From €3293EUR$3,450USD£2,759GBP
- Report
- March 2024
- 101 Pages
Asia Pacific
From €3293EUR$3,450USD£2,759GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2023
- 350 Pages
Global
From €3102EUR$3,250USD£2,599GBP
- Report
- January 2022
- 60 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- February 2021
- 50 Pages
Global
From €3102EUR$3,250USD£2,599GBP
- Report
- February 2024
- 245 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Clinical Trials
- January 2024
- 90 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Clinical Trials
- January 2024
- 280 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1909EUR$2,000USD£1,599GBP

Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body.
PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more